Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Ocellaris Pharma, Inc.
HiFiBiO Therapeutics
Actym Therapeutics, Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
Mayo Clinic
Elevation Oncology
Shanghai PerHum Therapeutics Co., Ltd.
University of Virginia
Pfizer
pharmaand GmbH
Children's National Research Institute
Nektar Therapeutics
National Institutes of Health Clinical Center (CC)
MacroGenics
Dana-Farber Cancer Institute
Cambridge University Hospitals NHS Foundation Trust
Tocagen Inc.
National Institutes of Health Clinical Center (CC)
Virginia Commonwealth University
Yale University
CureOne
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University Health Network, Toronto
Masonic Cancer Center, University of Minnesota
New York Medical College
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
University of South Florida
Pfizer
Emory University